2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Glenn N Levine; Eric R Bates; John A Bittl; Ralph G Brindis; Stephan D Fihn; Lee A Fleisher; Christopher B Granger; Richard A Lange; Michael J Mack; Laura Mauri; Roxana Mehran; Debabrata Mukherjee; L Kristin Newby; Patrick T O'Gara; Marc S Sabatine; Peter K Smith; Sidney C Smith Jr

doi:10.1016/j.jacc.2016.03.513

2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

J Am Coll Cardiol. 2016 Sep 6;68(10):1082-115. doi: 10.1016/j.jacc.2016.03.513. Epub 2016 Mar 29.

Authors

Glenn N Levine, Eric R Bates, John A Bittl, Ralph G Brindis, Stephan D Fihn, Lee A Fleisher, Christopher B Granger, Richard A Lange, Michael J Mack, Laura Mauri, Roxana Mehran, Debabrata Mukherjee, L Kristin Newby, Patrick T O'Gara, Marc S Sabatine, Peter K Smith, Sidney C Smith Jr

PMID: 27036918
DOI: 10.1016/j.jacc.2016.03.513

No abstract available

Keywords: ACC/AHA Clinical Practice Guideline; P2Y(12) inhibitor; acute coronary syndrome; aspirin; coronary artery disease; coronary stents; dual antiplatelet therapy (DAPT); focused update; stable ischemic heart disease.

Publication types

Practice Guideline

MeSH terms

Algorithms
Aspirin / administration & dosage*
Coronary Artery Disease / surgery*
Humans
Platelet Aggregation Inhibitors / administration & dosage*
Purinergic P2Y Receptor Antagonists / administration & dosage*
Time Factors

Substances

Platelet Aggregation Inhibitors
Purinergic P2Y Receptor Antagonists
Aspirin